Paola Mariela Saba Villarroel
Overview
Explore the profile of Paola Mariela Saba Villarroel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saba Villarroel P, Chaiphongpachara T, Nurtop E, Laojun S, Pangpoo-Nga T, Songhong T, et al.
Sci Rep
. 2025 Feb;
15(1):5406.
PMID: 39948185
No abstract available.
2.
Driouich J, Cochin M, Lingas G, Luciani L, Baronti C, Bernadin O, et al.
Biomed Pharmacother
. 2024 Jun;
177:116988.
PMID: 38897157
Therapeutic monoclonal antibodies have been successful in protecting vulnerable populations against SARS-CoV-2. However, their effectiveness has been hampered by the emergence of new variants. To adapt the therapeutic landscape, health...
3.
Saba Villarroel P, Chaiphongpachara T, Nurtop E, Laojun S, Pangpoo-Nga T, Songhong T, et al.
Sci Rep
. 2024 Jun;
14(1):13397.
PMID: 38862576
Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne virus with a mortality rate of up to 30%. First identified in China in 2009, it was later reported...
4.
Chaiphongpachara T, Laojun S, Changbunjong T, Wichit S, Saba Villarroel P
Acta Trop
. 2024 May;
256:107276.
PMID: 38821146
Culex gelidus (Diptera: Culicidae), an important vector of the Japanese encephalitis virus (JEV), contributes to human viral encephalitis in many Asian countries, including Thailand. This study represents the first investigation...
5.
Saba Villarroel P, Hamel R, Gumpangseth N, Yainoy S, Koomhin P, Misse D, et al.
PLoS Negl Trop Dis
. 2024 Apr;
18(4):e0011842.
PMID: 38630843
Background: Zika virus (ZIKV) has spread to five of the six World Health Organization (WHO) regions. Given the substantial number of asymptomatic infections and clinical presentations resembling those of other...
6.
Pouquet M, Decarreaux D, Di Domenico L, Sabbatini C, Prevot-Monsacre P, Fourie T, et al.
Sci Rep
. 2024 Mar;
14(1):5418.
PMID: 38443618
Data on the SARS-CoV-2 infection among primary health care workers (PHCWs) are scarce but essential to reflect on policy regarding prevention and control measures. We assessed the prevalence of PHCWs...
7.
Saba Villarroel P, Gumpangseth N, Songhong T, Yainoy S, Monteil A, Leaungwutiwong P, et al.
Front Public Health
. 2023 Jun;
11:1141483.
PMID: 37383270
The ongoing significant social, environmental, and economic changes in Southeast Asia (SEA) make the region highly vulnerable to the emergence and re-emergence of zoonotic viral diseases. In the last century,...
8.
Gallian P, Hoze N, Brisbarre N, Saba Villarroel P, Nurtop E, Isnard C, et al.
iScience
. 2023 Feb;
26(4):106222.
PMID: 36818722
We conducted a cross-sectional study for SARS-CoV-2 anti-S1 IgG prevalence in French blood donors (n = 32605), from March-2020 to January-2021. A mathematical model combined seroprevalence with a daily number...
9.
Decarreaux D, Sevila J, Masse S, Capai L, Fourie T, Saba Villarroel P, et al.
Int J Environ Res Public Health
. 2022 Nov;
19(22).
PMID: 36429974
Background: Uncertainties remain regarding the nature and durability of the humoral immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Aim: This study investigated immunoglobulin G response and neutralizing activity...
10.
Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution
Robineau O, Zins M, Touvier M, Wiernik E, Lemogne C, de Lamballerie X, et al.
JAMA Netw Open
. 2022 Nov;
5(11):e2240985.
PMID: 36350653
Importance: Persistent symptoms after SARS-CoV-2 infection are an emerging public health problem. The duration of these symptoms remains poorly documented. Objective: To describe the temporal dynamics of persistent symptoms after...